Publications (Filter: pharmaceutical industry)
-
Strategic Autonomy and the Competitiveness of Europe’s Innovative Pharmaceutical Sector: A Wake-up Call
It is high time for Europe to break its relative decline in the pharmaceutical sector. Europe used to be the preeminent region in the world for...
-
Strategic Autonomy and Long-term Innovation Competitiveness: On the Importance of Intellectual Property Rights for the Production of High-Value Medicines in the EU
Tags: competitiveness EU innovation intellectual property pharmaceutical industry strategic autonomyBy: Matthias BauerEurope’s political leaders have in recent months called for “European industrial autonomy”. Notions of dependency, sovereignty and resilience...
-
The Compounding Effect of Tariffs on Medicines: Estimating the Real Cost of Emerging Markets’ Protectionism
By: Matthias BauerEven low import tariff rates have a significant compounding effect on the final retail price of medicines, which in turn impacts on affordability....
-
PRICE TAGGING THE PRICELESS: International reference pricing for medicines in theory and practice
International reference pricing (IRP) has become a popular policy instrument in Europe as government seeks to curb healthcare costs and notably...
-
Beyond Geopolitics – The Case for a Free Trade Accord between Europe and Taiwan
Tags: automotive industry EU free trade agreements geopolitics Information and Communications Technology investment pharmaceutical industry Taiwan trade policyThis paper discusses the economics and geopolitics of EU Taiwan commercial relations and weighs the case for a free trade agreement (FTA) between...
-
Intellectual Property Rights, Pharmaceuticals and Foreign Direct Investment
Tags: foreign direct investment globalisation innovation intellectual property pharmaceutical industryIn response to the challenges and opportunities of globalisation, the pharmaceutical sector has evolved to become one of the most dynamic and...